Mark For: TANSTRIVE™ trademark registration is intended to cover the categories of pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases.
Status
2021-07-25 UTC
DEAD APPLICATION Refused Dismissed or Invalidated
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Domestic Representative
Bruce W. Longbottom
Attorney Name
Bruce W. Longbottom
Law Office Assigned
M30
Employee Name
MARTIN, LIEF ANDREW
Timeline
2015-02-12
Application Filed
2015-07-14
Published
2015-07-14
Published for Opposition
2017-08-31
Location: INTENT TO USE SECTION
2018-04-09
Abandon
2018-04-09
Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume
Bruce W. Longbottom Eli Lilly and Company Lilly Corporate Center Indianapolis, IN 46285
Good, Services, and Codes
International Codes:
5
U.S. Codes:
006,018,044,046,051,052
Type Code
Type
GS0051
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
Trademark Filing History
Description
Date
Proceeding Number
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
2018-04-09
ABANDONMENT - NO USE STATEMENT FILED
2018-04-09
99999
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2017-09-01
EXTENSION 4 GRANTED
2017-08-31
65362
CASE ASSIGNED TO INTENT TO USE PARALEGAL
2017-08-28
65362
TEAS EXTENSION RECEIVED
2017-08-16
EXTENSION 4 FILED
2017-08-16
65362
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2017-03-09
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2017-03-09
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2017-02-08
TEAS EXTENSION RECEIVED
2017-02-06
EXTENSION 3 GRANTED
2017-02-06
98765
EXTENSION 3 FILED
2017-02-06
98765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2016-07-19
EXTENSION 2 GRANTED
2016-07-18
61813
TEAS EXTENSION RECEIVED
2016-06-30
EXTENSION 2 FILED
2016-06-30
61813
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2016-03-03
EXTENSION 1 GRANTED
2016-03-02
61813
CASE ASSIGNED TO INTENT TO USE PARALEGAL
2016-02-29
61813
TEAS EXTENSION RECEIVED
2016-01-26
EXTENSION 1 FILED
2016-01-26
61813
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2015-09-08
PUBLISHED FOR OPPOSITION
2015-07-14
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2015-07-14
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2015-06-24
LAW OFFICE PUBLICATION REVIEW COMPLETED
2015-06-10
68171
ASSIGNED TO LIE
2015-06-10
68171
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2015-05-20
6328
EXAMINERS AMENDMENT E-MAILED
2015-05-20
6328
EXAMINERS AMENDMENT -WRITTEN
2015-05-20
85328
EXAMINER'S AMENDMENT ENTERED
2015-05-20
88888
APPROVED FOR PUB - PRINCIPAL REGISTER
2015-05-20
ASSIGNED TO EXAMINER
2015-05-19
85328
NOTICE OF PSEUDO MARK E-MAILED
2015-03-03
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.